Thursday, June 4, 2026

#MVIS

97 articles

MicroVision Stock Plummets 26% In Recent 10 Sessions - What's Next?

MicroVision Stock Plummets 26% In Recent 10 Sessions - What's Next?

ViaNews Editorial Team•Mar 26, 2024

Less Than One Hour Before The NASDAQ Open, MicroVision Is Up By 4%

Less Than One Hour Before The NASDAQ Open, MicroVision Is Up By 4%

ViaNews Editorial Team•Mar 18, 2024

MicroVision Already 7% Up, Almost Two Hours Before The NASDAQ Open

MicroVision Already 7% Up, Almost Two Hours Before The NASDAQ Open

ViaNews Editorial Team•Jan 2, 2024

LendingTree And Advaxis On The List Of Winners And Losers Of Thursday's US Session

LendingTree And Advaxis On The List Of Winners And Losers Of Thursday's US Session

ViaNews Editorial Team•Dec 7, 2023

MicroVision Stock Soars 31% In Just 21 Sessions - What's Driving The Surge?

MicroVision Stock Soars 31% In Just 21 Sessions - What's Driving The Surge?

ViaNews Editorial Team•Dec 5, 2023

MicroVision Stock Soars 29% In 10 Sessions: Is It Time To Invest?

MicroVision Stock Soars 29% In 10 Sessions: Is It Time To Invest?

ViaNews Editorial Team•Nov 28, 2023

ParkerVision And RiceBran Technologies On The List Of Winners And Losers Of Friday's US Session

ParkerVision And RiceBran Technologies On The List Of Winners And Losers Of Friday's US Session

ViaNews Editorial Team•Nov 24, 2023

Methes Energies International Ltd And National American University Holdings On The List Of Winners And Losers Of Thursday's US Session

Methes Energies International Ltd And National American University Holdings On The List Of Winners And Losers Of Thursday's US Session

ViaNews Editorial Team•Nov 23, 2023

MicroVision Stock 11.68% Up On Thursday

MicroVision Stock 11.68% Up On Thursday

ViaNews Editorial Team•Nov 16, 2023

Arcturus Therapeutics And Eli Lilly And Company On The List Of Winners And Losers Of Thursday's US Session

Arcturus Therapeutics And Eli Lilly And Company On The List Of Winners And Losers Of Thursday's US Session

ViaNews Editorial Team•Nov 16, 2023

China SXT Pharmaceuticals And Synlogic On The List Of Winners And Losers Of Tuesday's US Session

China SXT Pharmaceuticals And Synlogic On The List Of Winners And Losers Of Tuesday's US Session

ViaNews Editorial Team•Sep 19, 2023

MicroVision Stock Plummets 27% In 21 Sessions: Is It Time To Sell?

MicroVision Stock Plummets 27% In 21 Sessions: Is It Time To Sell?

ViaNews Editorial Team•Sep 7, 2023

This AI Guessed Tomorrow's Stock Price Correctly For Identiv And Internationa Flavors & Fragrances

This AI Guessed Tomorrow's Stock Price Correctly For Identiv And Internationa Flavors & Fragrances

ViaNews Editorial Team•Aug 30, 2023

Artificial Intelligence Predicts Next Session's Price Change For Rollins, Upland Software, U.S. Bancorp

Artificial Intelligence Predicts Next Session's Price Change For Rollins, Upland Software, U.S. Bancorp

ViaNews Editorial Team•Aug 28, 2023

MicroVision Stock Falls 34% In 21 Sessions - What Caused This Decline?

MicroVision Stock Falls 34% In 21 Sessions - What Caused This Decline?

Via News Just in•Aug 28, 2023

MicroVision Stock Falls By 16% In The Last 5 Sessions

MicroVision Stock Falls By 16% In The Last 5 Sessions

ViaNews Editorial Team•Aug 7, 2023

Aurora Cannabis And First Horizon National On The List Of Winners And Losers Of Monday's US Premarket Session

Aurora Cannabis And First Horizon National On The List Of Winners And Losers Of Monday's US Premarket Session

ViaNews Editorial Team•Aug 7, 2023

Niu Technologies And NeuroMetrix On The List Of Winners And Losers Of Tuesday's US Premarket Session

Niu Technologies And NeuroMetrix On The List Of Winners And Losers Of Tuesday's US Premarket Session

ViaNews Editorial Team•Jul 25, 2023

NeuroMetrix And Sun Communities On The List Of Winners And Losers Of Tuesday's US Premarket Session

NeuroMetrix And Sun Communities On The List Of Winners And Losers Of Tuesday's US Premarket Session

ViaNews Editorial Team•Jul 18, 2023

MicroVision Stock Bearish By 29% In The Last 21 Sessions

MicroVision Stock Bearish By 29% In The Last 21 Sessions

ViaNews Editorial Team•Jul 13, 2023